These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 19837560)
1. Venous thromboembolism: management by American Association of Hip and Knee Surgeons. Markel DC; York S; Liston MJ; Flynn JC; Barnes CL; Davis CM; J Arthroplasty; 2010 Jan; 25(1):3-9.e1-2. PubMed ID: 19837560 [TBL] [Abstract][Full Text] [Related]
2. Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons. Anderson FA; Huang W; Friedman RJ; Kwong LM; Lieberman JR; Pellegrini VD; J Arthroplasty; 2012 May; 27(5):659-66.e5. PubMed ID: 22035977 [TBL] [Abstract][Full Text] [Related]
3. Warfarin for venous thromboembolism prophylaxis after elective hip or knee arthroplasty: exploring the evidence, guidelines, and challenges remaining. Dager WE Ann Pharmacother; 2012 Jan; 46(1):79-88. PubMed ID: 22202495 [TBL] [Abstract][Full Text] [Related]
4. Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty--insights from the Multinational Global Orthopaedic Registry (GLORY). Friedman RJ; Gallus A; Gil-Garay E; FitzGerald G; Cushner F Am J Orthop (Belle Mead NJ); 2010 Sep; 39(9 Suppl):14-21. PubMed ID: 21290027 [TBL] [Abstract][Full Text] [Related]
5. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery. Colwell C; Mouret P Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914 [TBL] [Abstract][Full Text] [Related]
6. Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. Lachiewicz PF Orthopedics; 2009 Dec; 32(12 Suppl):74-8. PubMed ID: 20201480 [TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolic disease after total hip and knee arthroplasty: current perspectives in a regulated environment. Pellegrini VD; Sharrock NE; Paiement GD; Morris R; Warwick DJ Instr Course Lect; 2008; 57():637-61. PubMed ID: 18399613 [TBL] [Abstract][Full Text] [Related]
8. The Australian arthroplasty thromboprophylaxis survey. Molnar RB; Jenkin DE; Millar MJ; Campbell D; Harris IA J Arthroplasty; 2012 Feb; 27(2):173-9. PubMed ID: 21752576 [TBL] [Abstract][Full Text] [Related]
9. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates. Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257 [TBL] [Abstract][Full Text] [Related]
10. A prospective comparison of warfarin to aspirin for thromboprophylaxis in total hip and total knee arthroplasty. Intermountain Joint Replacement Center Writing Committee J Arthroplasty; 2012 Jan; 27(1):1-9.e2. PubMed ID: 21621959 [TBL] [Abstract][Full Text] [Related]
11. Current guidelines for total joint VTE prophylaxis: dawn of a new day. Barrack RL J Bone Joint Surg Br; 2012 Nov; 94(11 Suppl A):3-7. PubMed ID: 23118370 [TBL] [Abstract][Full Text] [Related]
12. Comparing and contrasting current guidelines for venous thromboembolism prophylaxis after total hip and total knee arthroplasty. Lachiewicz PF Instr Course Lect; 2011; 60():301-7. PubMed ID: 21553782 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from a single institution. Lewis CG; Inneh IA; Schutzer SF; Grady-Benson J J Bone Joint Surg Am; 2014 Aug; 96(16):1327-32. PubMed ID: 25143492 [TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolic disease after total hip and knee arthroplasty. Haas SB; Barrack RL; Westrich G Instr Course Lect; 2009; 58():781-93. PubMed ID: 19385586 [TBL] [Abstract][Full Text] [Related]
15. Warfarin prophylaxis in patients after total knee or hip arthroplasty--international normalized ratio patterns and venous thromboembolism. Nordstrom BL; Kachroo S; Fraeman KH; Nutescu EA; Schein JR; Fisher A; Bookhart BK Curr Med Res Opin; 2011 Oct; 27(10):1973-85. PubMed ID: 21919556 [TBL] [Abstract][Full Text] [Related]
16. Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence. Stewart DW; Freshour JE Ann Pharmacother; 2013 Jan; 47(1):63-74. PubMed ID: 23324504 [TBL] [Abstract][Full Text] [Related]
17. Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes. Penning-van Beest FJ; Overbeek JA; Meijer WM; Woodruff K; Jackson J; van der Vis H; van der Linden P; Herings RM Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):972-8. PubMed ID: 21748826 [TBL] [Abstract][Full Text] [Related]
18. Deep venous thrombosis prophylaxis for total joint arthroplasty: American Academy of Orthopaedic Surgeons guidelines. Parvizi J; Azzam K; Rothman RH J Arthroplasty; 2008 Oct; 23(7 Suppl):2-5. PubMed ID: 18922368 [TBL] [Abstract][Full Text] [Related]
19. Are the national orthopaedic thromboprophylaxis guidelines appropriate? Mirkazemi C; Bereznicki LR; Peterson GM ANZ J Surg; 2012 Dec; 82(12):913-7. PubMed ID: 22989056 [TBL] [Abstract][Full Text] [Related]
20. Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban. Friedman RJ; Sengupta N; Lees M Expert Rev Pharmacoecon Outcomes Res; 2011 Jun; 11(3):299-306. PubMed ID: 21671699 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]